|
Market Closed -
NYSE
00:00:03 27/10/2026 +04
|
Pre-market 16:34:30 | |||
| 20.43 USD | +0.94% |
|
20.20 | -1.15% |
| 10-26 | Takeda Pharmaceutical Eyes 2027 Japan Filing for Gastric Cancer Treatment | MT |
| 10-25 | Takeda to seek Japan approval for gastric cancer drug next year | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 65.39B | |||||
| 1,140B | |||||
| 641B | |||||
| 507B | |||||
| 383B | |||||
| 347B |
Select your edition
All financial news and data tailored to specific country editions
